Global Isosorbide Mononitrate Market Insights and Forecast to 2027

Isosorbide mononitrate is a drug used principally in the treatment of angina pectoris and acts by dilating the blood vessels so as to reduce the blood pressure.

Market Analysis and Insights: Global Isosorbide Mononitrate Market
The global Isosorbide Mononitrate market is valued at US$ XX million in 2019. The market size will reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.

Global Isosorbide Mononitrate Scope and Market Size
Isosorbide Mononitrate market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Isosorbide Mononitrate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
10 mg Tablet
20 mg Tablet

Segment by Application
Treatment of Angina Pectoris
Others

By Company
Teva
Merck
Nesher Pharmaceuticals
Taj pharmaceutical
AMRI
Intas Pharmaceuticals
Sandoz
Globus Remedies
Intas Pharmaceuticals
Shandong Fangming Pharmaceutical Group
ReYoung Pharmaceutical

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Details
QYR-17973906

14-Apr-2021

114
License